Patient Leaflet Updated 30-Oct-2026 | Chugai Pharma UK Limited
Akynzeo 300mg/0.5mg oral suspension
Akynzeo 300 mg/0.5 mg oral suspension in sachet
netupitant/palonosetron
1. What Akynzeo is and what it is used for
2. What you need to know before you take Akynzeo
3. How to take Akynzeo
4. Possible side effects
5. How to store Akynzeo
6. Contents of the pack and other information
Akynzeo contains two active substances called:
Akynzeo is used to help prevent adults with cancer feeling sick (nausea) or being sick (vomiting) while having cancer treatment called ‘chemotherapy’.
Chemotherapy medicines can cause the body to release substances called serotonin and substance P. This stimulates the vomiting centre in the brain, making you feel or be sick. The medicines in Akynzeo attach to the receptors in the nervous system through which serotonin and substance P work: netupitant (an NK1 receptor antagonist) blocks the receptors for substance P, and palonosetron (a 5 HT3 receptor antagonist) blocks certain receptors for serotonin. By blocking the actions of substance P and serotonin in this way, the medicines help prevent the stimulation of the vomiting centre and the resulting sickness.
Talk to your doctor, pharmacist or nurse before taking Akynzeo if:
If any of the above apply to you (or you are not sure), talk to your doctor, pharmacist or nurse before taking Akynzeo.
Akynzeo should not be taken by children and adolescents under 18 years.
Tell your doctor, pharmacist or nurse if you are taking, have recently taken or might take any other medicines.
In particular tell your doctor, pharmacist or nurse if you are taking any of the following medicines:
Also tell your doctor, pharmacist or nurse if you are taking any of the following medicines as your doctor may need to change the dose of these other medicines:
If any of the above apply to you (or you are not sure), talk to your doctor, pharmacist or nurse before taking Akynzeo.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.
Do not take Akynzeo if you are pregnant or if you are a woman of childbearing potential not using contraception.
Do not breast-feed if you are taking Akynzeo. This is because it is not known whether the medicine passes into breast milk.
You may feel dizzy or tired after taking Akynzeo. If this happens, do not drive or use any tools or machines.
Sorbitol is a source of fructose. If your doctor has told you that you (or your child) have an intolerance to some sugars or if you have been diagnosed with hereditary fructose intolerance (HFI), a rare genetic disorder in which a person cannot break down fructose, talk to your doctor before you (or your child) take or receive this medicine.
This medicine contains 32.2 mg sodium (main component of cooking/table salt) in each sachet. This is equivalent to 1.61% of the recommended maximum daily dietary intake of sodium for an adult.
This medicine contains 2.60 mg potassium per sachet. To be taken into consideration by patients with reduced kidney function or patients on a controlled potassium diet.
Always take this medicine exactly as your doctor has told you. Check with your doctor, pharmacist or nurse if you are not sure.
Akynzeo is taken before the chemotherapy to prevent sickness and feelings of sickness from developing. Do not take Akynzeo in the days after you have chemotherapy - unless you are about to have another chemotherapy cycle.
The usual dose is 1 sachet. If you think you may have taken more than you should, tell your doctor straight away. The symptoms of overdose may include headache, dizziness, constipation, anxiety, palpitations, euphoric mood and pain in the legs.
If you think you have forgotten to take your dose, tell your doctor straight away.
Akynzeo is taken to help prevent you feeling and being sick when you are having chemotherapy. If you do not want to take Akynzeo, discuss this with your doctor. If you decide not to take Akynzeo (or another similar medicine), your chemotherapy is likely to make you feel sick and be sick.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Stop taking Akynzeo and tell your doctor straight away if you notice the following serious side effect - you may need urgent medical treatment:
Very rare: (may affect up to 1 in 10 000 people)
Tell your doctor, pharmacist or nurse if you notice any of the following side effects:
Common: (may affect up to 1 in 10 people)
Uncommon: (may affect up to 1 in 100 people)
Rare: (may affect up to 1 in 1 000 people)
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and sachet after ‘EXP’.
The expiry date refers to the last day of that month.
This medicine does not require any special storage conditions.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
This medicine contains sodium, potassium and sorbitol (E420), see section 2 for more information.
White to off-white homogeneous suspension.
Pack size containing 1 or 4 PET/ALU/PE (polyester /aluminium/polyethylene) sachet(s) in a single outer carton.
Not all pack sizes may be marketed.
This leaflet was last revised in October 2026
Building 4, Chiswick Park, 566 Chiswick High Road, Chiswick, London, W4 5YE
http://www.chugai.eu/our-medicines/uk/